Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators. Nyang'wa BT, et al. Among authors: solodovnikova v. N Engl J Med. 2022 Dec 22;387(25):2331-2343. doi: 10.1056/NEJMoa2117166. N Engl J Med. 2022. PMID: 36546625 Clinical Trial.
Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis.
Skrahin A, Jenkins HE, Hurevich H, Solodovnikova V, Isaikina Y, Klimuk D, Rohava Z, Skrahina A. Skrahin A, et al. Among authors: solodovnikova v. J Clin Tuberc Other Mycobact Dis. 2016 Aug;4:21-27. doi: 10.1016/j.jctube.2016.05.003. J Clin Tuberc Other Mycobact Dis. 2016. PMID: 27284577 Free PMC article.
Treatment Outcomes in Multidrug-Resistant Tuberculosis.
Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBNET. Günther G, et al. Among authors: solodovnikova v. N Engl J Med. 2016 Sep 15;375(11):1103-5. doi: 10.1056/NEJMc1603274. N Engl J Med. 2016. PMID: 27626539 Free article. No abstract available.
Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.
Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Magis-Escurra C, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; for TBNET. Günther G, et al. Among authors: solodovnikova v. Am J Respir Crit Care Med. 2018 Aug 1;198(3):379-386. doi: 10.1164/rccm.201710-2141OC. Am J Respir Crit Care Med. 2018. PMID: 29509468
Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19.
Solodovnikova V, Kumar AMV, Hurevich H, Sereda Y, Auchynka V, Katovich D, Klimuk D, Skrahin A, Setkina S, Charnysh I, Yedilbayev A, Skrahina A. Solodovnikova V, et al. Monaldi Arch Chest Dis. 2021 Jan 14;91(1). doi: 10.4081/monaldi.2021.1646. Monaldi Arch Chest Dis. 2021. PMID: 33470080 Free article.
Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18.
Auchynka V, Kumar AMV, Hurevich H, Sereda Y, Solodovnikova V, Katovich D, Setkina S, Yedilbayev A, Skrahin A, Skrahina A. Auchynka V, et al. Among authors: solodovnikova v. Monaldi Arch Chest Dis. 2021 Jan 14;91(1). doi: 10.4081/monaldi.2021.1647. Monaldi Arch Chest Dis. 2021. PMID: 33470081 Free article.
Safety of prolonged treatment with bedaquiline in programmatic conditions.
Zhurkin D, Gurbanova E, Campbell JR, Menzies D, Setkina S, Hurevich H, Solodovnikova V, Viatushka D, Altraja A, Skrahina A. Zhurkin D, et al. Among authors: solodovnikova v. ERJ Open Res. 2022 May 16;8(2):00685-2021. doi: 10.1183/23120541.00685-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35586446 Free PMC article.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, Rajaram S, Rassool M, McHugh T, Spigelman M, Moore DA, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL team. Nyang'wa BT, et al. Among authors: solodovnikova v. Lancet Respir Med. 2024 Feb;12(2):117-128. doi: 10.1016/S2213-2600(23)00389-2. Epub 2023 Nov 16. Lancet Respir Med. 2024. PMID: 37980911 Free article. Clinical Trial.
19 results